Vyome Holdings, Inc. (NASDAQ:HIND) Sees Significant Drop in Short Interest

Vyome Holdings, Inc. (NASDAQ:HIND) saw a significant drop in short interest during the month of May. As of May 29th, there was short interest totaling 77,671 shares, a drop of 36.9% from the May 14th total of 123,132 shares. Currently, 1.7% of the company’s shares are sold short. Based on an average trading volume of 25,890 shares, the days-to-cover ratio is presently 3.0 days.

Analyst Ratings Changes

Several research firms have issued reports on HIND. Zacks Research raised Vyome to a “hold” rating in a research note on Wednesday, May 6th. Litchfield Hills Research began coverage on Vyome in a research note on Monday, May 4th. They set a “buy” rating for the company. Finally, Weiss Ratings raised Vyome from a “sell (e)” rating to a “sell (e+)” rating in a research note on Friday, May 1st. Three equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $15.00.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Vyome stock. Geode Capital Management LLC bought a new position in shares of Vyome Holdings, Inc. (NASDAQ:HIND) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 11,934 shares of the company’s stock, valued at approximately $41,000. Geode Capital Management LLC owned approximately 0.21% of Vyome at the end of the most recent reporting period. Institutional investors own 22.06% of the company’s stock.

Vyome Stock Performance

Shares of NASDAQ HIND traded up $0.03 during trading on Tuesday, reaching $2.20. The stock had a trading volume of 10,173 shares, compared to its average volume of 22,787. Vyome has a fifty-two week low of $1.75 and a fifty-two week high of $18.60. The business’s 50-day moving average price is $2.17 and its 200-day moving average price is $2.81. The company has a market cap of $15.44 million, a P/E ratio of -0.18 and a beta of 1.48.

Vyome (NASDAQ:HIND) last announced its quarterly earnings data on Tuesday, May 12th. The company reported ($0.15) earnings per share for the quarter. The business had revenue of $0.03 million during the quarter. Vyome had a negative net margin of 270.58% and a negative return on equity of 203.92%. Analysts forecast that Vyome will post -0.6 EPS for the current fiscal year.

About Vyome

ReShape Lifesciences Inc, a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company’s product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract.